Yep you guys hit it on the head, $1 ( $274miill) is still a low MC for a advanced biotech play ( if thats what we call ourselves )
So again IMO our MC is way to low for what management have achieved over the last 24 Months, and we are only one "good" announcement away from a re-rate !
Volume and SP action of late suggests we are hopefully geeting closer.
In The News, page-4
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
